Intervention not reported
Albumin plus midodrine plus octreotide plus pentoxifylline (No RCTs) · people with hepatorenal syndrome with decompensated liver cirrhosis
It is very uncertain whether the intervention changes albumin plus midodrine plus octreotide plus pentoxifylline (No RCTs) (very low certainty).
1 finding from 1 review
- Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta‐analysis 2019 · Cochrane Headline outcomes onlyHR 0.5 [0.06, 4.07]Studies not reportedVery low